rxstat › Shortages › Desvenlafaxine
Desvenlafaxine shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Desvenlafaxine products are in shortage in Canada (2 of 17 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jul 31, 2026.
In shortage since
Nov 3, 2025
Est. full return
Jul 31, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageTARO-DESVENLAFAXINE
50MG · TABLET (EXTENDED-RELEASE) · TARO PHARMACEUTICALS INC
DIN 02532158 · since May 1, 2026, est. end Jul 31, 2026 · Disruption of the manufacture of the drug.
Active shortageTARO-DESVENLAFAXINE
50MG · TABLET (EXTENDED-RELEASE) · TARO PHARMACEUTICALS INC
DIN 02532158 · since May 1, 2026, est. end Jul 31, 2026 · Disruption of the manufacture of the drug.
Active shortageTARO-DESVENLAFAXINE
100MG · TABLET (EXTENDED-RELEASE) · TARO PHARMACEUTICALS INC
DIN 02532166 · since Nov 3, 2025, est. end Jul 31, 2026 · Disruption of the manufacture of the drug.
ResolvedTEVA-DESVENLAFAXINE
50MG · TABLET (EXTENDED-RELEASE) · TEVA CANADA LIMITED
DIN 02458217 · ended May 31, 2026 · Disruption of the manufacture of the drug.
ResolvedSANDOZ DESVENLAFAXINE
50MG · TABLET (EXTENDED-RELEASE) · SANDOZ CANADA INCORPORATED
DIN 02538415 · ended Feb 23, 2026 · Demand increase for the drug.
ResolvedAPO-DESVENLAFAXINE
50MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02466988 · ended Jan 2, 2026 · Disruption of the manufacture of the drug.
ResolvedAPO-DESVENLAFAXINE
50MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02466988 · ended Jan 2, 2026 · Disruption of the manufacture of the drug.
ResolvedDESVENLAFAXINE
50MG · TABLET (EXTENDED-RELEASE) · SANIS HEALTH INC
DIN 02535106 · ended Nov 13, 2024 · Disruption of the manufacture of the drug.
ResolvedDESVENLAFAXINE
100MG · TABLET (EXTENDED-RELEASE) · SANIS HEALTH INC
DIN 02535114 · ended Nov 13, 2024 · Disruption of the manufacture of the drug.
ResolvedDESVENLAFAXINE
100MG · TABLET (EXTENDED-RELEASE) · PRO DOC LIMITEE
DIN 02543680 · ended Oct 25, 2024 · Delay in shipping of the drug.
ResolvedAPO-DESVENLAFAXINE
100MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02466996 · ended Oct 24, 2024 · Disruption of the manufacture of the drug.
ResolvedJAMP DESVENLAFAXINE
50MG · TABLET (EXTENDED-RELEASE) · JAMP PHARMA CORPORATION
DIN 02495139 · ended Jul 16, 2024 · Disruption of the manufacture of the drug.
Showing 12 of 45 reports. All reports are on file with Health Canada.
What's happening
Desvenlafaxine is currently affected by 2 active shortage reports filed with Health Canada by TARO PHARMACEUTICALS INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Desvenlafaxine is classified under “ANTIDEPRESSANTS” (ATC N06AX).
Recent changes
Common questions
When will Desvenlafaxine be back in stock in Canada?
The latest manufacturer estimate is Jul 31, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Desvenlafaxine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.